Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents

作者: Xiaojie Zhang , Rubing Wang , German Ruiz Perez , Guanglin Chen , Qiang Zhang

DOI: 10.1016/J.BMC.2016.08.006

关键词:

摘要: In search of more effective chemotherapeutics for the treatment castration-resistant prostate cancer and inspired by curcumin analogues, twenty five (1E,3E,6E,8E)-1,9-diarylnona-1,3,6,8-tetraen-5-ones bearing two identical terminal heteroaromatic rings have been successfully synthesized through Wittig reaction followed Horner-Wadsworth-Emmons reaction. Twenty-three them are new compounds. The WST-1 cell proliferation assay was employed to assess their anti-proliferative effects toward both androgen-sensitive androgen-insensitive human lines. Eighteen out twenty-five compounds possess significantly improved potency as compared with curcumin. optimal compound, 78, is 14- 23-fold potent than in inhibiting proliferation. It can be concluded from our data that 1,9-diarylnona-1,3,6,8-tetraen-5-one serve a potential scaffold development anti-prostate agents pyridine-4-yls quinolin-4-yl act enhanced this scaffold. Two most compounds, 68 75, effectively suppress PC-3 activating apoptosis arresting cycle G0/G1 phase.

参考文章(28)
Anca Miron, Elena Creţu, Adriana Trifan, Al Vasincu, Plant-derived anticancer agents - curcumin in cancer prevention and treatment. Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i. ,vol. 116, pp. 1223- 1229 ,(2012)
Alok C. Bharti, Bharat B. Aggarwal, Anushree Kumar, Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research. ,vol. 23, pp. 363- 398 ,(2003)
Ajay Goel, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal, Curcumin as “Curecumin”: From kitchen to clinic Biochemical Pharmacology. ,vol. 75, pp. 787- 809 ,(2008) , 10.1016/J.BCP.2007.08.016
Claire Corcoran, Sweta Rani, Keith O’Brien, Amanda O’Neill, Maria Prencipe, Rizwan Sheikh, Glenn Webb, Ray McDermott, William Watson, John Crown, Lorraine O’Driscoll, Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes PLoS ONE. ,vol. 7, pp. e50999- ,(2012) , 10.1371/JOURNAL.PONE.0050999
Preetha Anand, Sherin G. Thomas, Ajaikumar B. Kunnumakkara, Chitra Sundaram, Kuzhuvelil B. Harikumar, Bokyung Sung, Sheeja T. Tharakan, Krishna Misra, Indira K. Priyadarsini, Kallikat N. Rajasekharan, Bharat B. Aggarwal, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology. ,vol. 76, pp. 1590- 1611 ,(2008) , 10.1016/J.BCP.2008.08.008
Dhanya Nambiar, Rana P. Singh, Advances in prostate cancer chemoprevention: a translational perspective. Nutrition and Cancer. ,vol. 65, pp. 12- 25 ,(2013) , 10.1080/01635581.2013.785006
Marie-Hélène Teiten, François Gaascht, Serge Eifes, Mario Dicato, Marc Diederich, Chemopreventive potential of curcumin in prostate cancer. Genes and Nutrition. ,vol. 5, pp. 61- 74 ,(2010) , 10.1007/S12263-009-0152-3
Brian J. Feldman, David Feldman, The development of androgen-independent prostate cancer Nature Reviews Cancer. ,vol. 1, pp. 34- 45 ,(2001) , 10.1038/35094009
Dinesh Kumar Agrawal, Pushpesh Kumar Mishra, Curcumin and its analogues: potential anticancer agents. Medicinal Research Reviews. ,vol. 30, pp. 818- 860 ,(2009) , 10.1002/MED.20188
Masaki Seto, Naoki Miyamoto, Katsuji Aikawa, Yoshio Aramaki, Naoyuki Kanzaki, Yuji Iizawa, Masanori Baba, Mitsuru Shiraishi, Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety. Bioorganic & Medicinal Chemistry. ,vol. 13, pp. 363- 386 ,(2005) , 10.1016/J.BMC.2004.10.021